Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour ...
A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...